This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Grail, Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Weng In Chu: Innovator in Viral Nucleic Acid Analysis
Introduction
Weng In Chu is a notable inventor based in the Special Administrative Region of China. He has made significant contributions to the field of viral nucleic acid analysis, particularly in the context of detecting pathogens.
Latest Patents
Weng In Chu holds a patent for "Methods for analyzing viral nucleic acid." This patent provides methods, systems, and computer-readable mediums for detecting nucleic acid from pathogens, such as the Epstein-Barr virus (EBV), in cell-free nucleic samples from individuals at risk of conditions like nasopharyngeal carcinoma (NPC). The innovative methods can be utilized to screen for the presence of NPC using thresholds that are adjusted based on sample attributes. He has 1 patent to his name.
Career Highlights
Weng In Chu is associated with Grail, Inc., where he applies his expertise in viral analysis. His work is pivotal in advancing diagnostic methods that can lead to early detection of serious health conditions.
Collaborations
He has collaborated with notable colleagues in the field, including Yuk-Ming Dennis Lo and Kwan Chee Chan. Their combined efforts contribute to the advancement of medical diagnostics and research.
Conclusion
Weng In Chu's innovative work in viral nucleic acid analysis exemplifies the impact of scientific research on healthcare. His contributions are vital for improving diagnostic methods and enhancing patient outcomes.